COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective.
作者信息
Loh Kah Poh, Soto-Perez-de-Celis Enrique, Mislang Anna Rachelle, Chan Wing-Lok, Battisti Nicolò Matteo Luca
机构信息
Division of Hematology and Oncology, Department of Medicine, James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.
Department of Geriatrics, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
出版信息
Lancet Healthy Longev. 2021 May;2(5):e240-e242. doi: 10.1016/S2666-7568(21)00060-X. Epub 2021 May 6.
Abstract
摘要
相似文献
1
COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective.
Lancet Healthy Longev. 2021 May;2(5):e240-e242. doi: 10.1016/S2666-7568(21)00060-X. Epub 2021 May 6.
2
Updated International Society of Geriatric Oncology COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.
J Geriatr Oncol. 2022 Sep;13(7):1054-1057. doi: 10.1016/j.jgo.2022.07.005. Epub 2022 Jul 15.
3
Highlighting selected research conducted in older patients presented at the European Society for Medical Oncology (ESMO) 2022 Congress - a Young International Society of Geriatric Oncology (SIOG) perspective.
J Geriatr Oncol. 2023 Mar;14(2):101413. doi: 10.1016/j.jgo.2022.12.001. Epub 2023 Jan 19.
4
Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.
J Geriatr Oncol. 2020 Nov;11(8):1190-1198. doi: 10.1016/j.jgo.2020.07.008. Epub 2020 Jul 16.
5
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective.
J Geriatr Oncol. 2020 Sep;11(7):1175-1181. doi: 10.1016/j.jgo.2020.05.001. Epub 2020 May 10.
6
COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
Clin J Oncol Nurs. 2021 Feb 1;25(1):76-84. doi: 10.1188/21.CJON.76-84.
7
Geriatric screening in older adults with cancer - A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.
J Geriatr Oncol. 2022 Apr;13(3):374-377. doi: 10.1016/j.jgo.2021.09.003. Epub 2021 Sep 8.
8
Management of anaphylaxis due to COVID-19 vaccines in the elderly.
Allergy. 2021 Oct;76(10):2952-2964. doi: 10.1111/all.14838.
9
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients.
Eur J Cancer. 2019 Jul;116:116-136. doi: 10.1016/j.ejca.2019.04.031. Epub 2019 Jun 10.
10
Ideal medication review in older patients with cancer should include evaluation of frailty and prescription omission: Comment on the perspective "How-to-guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Group initiative".
J Geriatr Oncol. 2022 Nov;13(8):1281-1282. doi: 10.1016/j.jgo.2022.09.004. Epub 2022 Sep 14.
引用本文的文献
1
Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model.
Front Public Health. 2023 Aug 3;11:1236376. doi: 10.3389/fpubh.2023.1236376. eCollection 2023.
2
Healthcare providers' attitudes towards delay in cancer treatment during COVID-19 pandemic.
J Geriatr Oncol. 2023 Mar;14(2):101438. doi: 10.1016/j.jgo.2023.101438. Epub 2023 Jan 17.
本文引用的文献
1
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Lancet Infect Dis. 2021 Jun;21(6):803-812. doi: 10.1016/S1473-3099(20)30987-7. Epub 2021 Feb 3.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
4
The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age.
Sci Rep. 2020 Oct 6;10(1):16642. doi: 10.1038/s41598-020-73777-8.
5
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3. Epub 2020 Jun 15.
6
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28.
Zotero 插件